603259 药明康德
2026/09 - 九个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额17,193,15617,203,16212,406,51513,386,91210,616,030
投资活动产生之现金流量净额(13,891,990)(1,945,110)(5,518,177)(7,560,534)(9,690,286)
筹资活动产生之现金流量净额(2,481,516)1,123,541(3,832,191)(3,941,384)(1,277,808)
汇率变动对现金及现金等价物的影响(749,382)(370,473)387,525132,140160,633
现金及现金等价物净增加/(减少)70,26816,011,1193,443,6722,017,135(191,432)
期初现金及现金等价物余额29,455,83113,444,71110,001,0397,983,9048,175,336
期末现金及现金等价物余额29,526,09829,455,83113,444,71110,001,0397,983,904